Sunniva Stock Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Sunniva are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Sunniva has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Sunniva is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 11.4 M | |
| Total Cashflows From Investing Activities | -49.4 M |
Sunniva |
Sunniva Relative Risk vs. Return Landscape
If you would invest 0.00 in Sunniva on November 18, 2025 and sell it today you would earn a total of 0.00 from holding Sunniva or generate 0.0% return on investment over 90 days. Sunniva is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Sunniva, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Sunniva Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Sunniva for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Sunniva can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Sunniva generated a negative expected return over the last 90 days | |
| Sunniva has some characteristics of a very speculative penny stock | |
| Sunniva has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.79 M. Net Loss for the year was (29.05 M) with profit before overhead, payroll, taxes, and interest of 7.8 M. | |
| Sunniva has accumulated about 304 K in cash with (16.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Sunniva Fundamentals Growth
Sunniva Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Sunniva, and Sunniva fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sunniva Pink Sheet performance.
| Return On Equity | -0.64 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (1.43) % | |||
| Operating Margin | (0.88) % | |||
| Current Valuation | 46.08 M | |||
| Shares Outstanding | 39.21 M | |||
| Price To Book | 0.04 X | |||
| Price To Sales | 0 X | |||
| Revenue | 18.79 M | |||
| EBITDA | (25.47 M) | |||
| Cash And Equivalents | 304 K | |||
| Cash Per Share | 0.01 X | |||
| Debt To Equity | 1.07 % | |||
| Book Value Per Share | 1.37 X | |||
| Cash Flow From Operations | (16.28 M) | |||
| Earnings Per Share | (1.01) X | |||
| Total Asset | 125.32 M | |||
About Sunniva Performance
By analyzing Sunniva's fundamental ratios, stakeholders can gain valuable insights into Sunniva's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sunniva has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sunniva has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada. Sunniva operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Sunniva performance evaluation
Checking the ongoing alerts about Sunniva for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Sunniva help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sunniva generated a negative expected return over the last 90 days | |
| Sunniva has some characteristics of a very speculative penny stock | |
| Sunniva has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.79 M. Net Loss for the year was (29.05 M) with profit before overhead, payroll, taxes, and interest of 7.8 M. | |
| Sunniva has accumulated about 304 K in cash with (16.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Sunniva's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sunniva's stock is overvalued or undervalued compared to its peers.
- Examining Sunniva's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sunniva's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sunniva's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sunniva's pink sheet. These opinions can provide insight into Sunniva's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sunniva Pink Sheet analysis
When running Sunniva's price analysis, check to measure Sunniva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunniva is operating at the current time. Most of Sunniva's value examination focuses on studying past and present price action to predict the probability of Sunniva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunniva's price. Additionally, you may evaluate how the addition of Sunniva to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |